Basic Research
Copyright ©The Author(s) 2004.
World J Gastroenterol. Jan 15, 2004; 10(2): 250-254
Published online Jan 15, 2004. doi: 10.3748/wjg.v10.i2.250
Table 1 Serum ALT, AST, NO2-/NO3- and hepatic NOS activity (-x±s)
GroupnALTASTNO2-/NO3-NOS
(nkat/L)(nkat/L)(μmol/L)(KU/g)
Control1035.8 ± 7.964.5 ± 20.821.8 ± 13.70.65 ± 0.08
Ovx1031.6 ± 6.566.4 ± 18.319.3 ± 11.20.54 ± 0.33
Ovx+E938.5 ± 11.268.4 ± 21.284.8 ± 24.9ac2.57 ± 1.06ac
CCl49540 ± 252a631 ± 268a55.3 ± 23.1a1.65 ± 0.46a
CCl4+Ovx10658 ± 220a697 ± 240a53.7 ± 17.1a1.73 ± 0.71a
CCl4+E8314 ± 163c302 ± 153c87.5 ± 23.6c2.68 ± 1.17c
CCl4+Ovx+E9311 ± 146c321 ± 121c93.3 ± 24.2c2.49 ± 1.20c
Table 2 Effects of ovariectomy and estradiol on histological scores of CCl4– induced hepatic fibrosis
GroupnHepatic fibrosis scores
-++++++++++
Control10100000
Ovx10100000
Ovx+E990000
CCl4902231
CCl4+Ovxa1000253
CCl4+Ea804210
CCl4+Ovx+Ea905220